Harold Hamm Diabetes Center Researchers Earn Grant to Study Liver Disease in Children

More than 30% of children who are obese will eventually be diagnosed with non-alcoholic fatty liver disease, or NAFLD, a silently progressing condition that sometimes isn’t discovered until a child’s liver is stiffened with fibrosis.

Children born to obese mothers face a higher risk of developing NAFLD, but the exact reasons why remain unknown. Three researchers at OU Health Harold Hamm Diabetes Center have been awarded a $2.3 million grant from the National Institutes of Health to investigate the role of the microbiome – the millions of bacteria in a person’s gut – and how the microbes passed from mother to child contribute to the onset of NAFLD. The researchers are also testing a nutritional compound for its potential to counter negative changes in the microbiome, thereby lowering the risk for NAFLD.

Babies receive their first microbes from their mothers as they travel through the birth canal, breast feed, and have skin-to-skin contact. The microbiome plays a major role in how the immune system develops, beginning soon after birth. By age 3, a child’s microbiome is established, but things that disrupt its development in the first 1,000 days can alter the infant’s early immune system with significant consequences in later life. A primary suspect in that disruption is what the mother eats during pregnancy.

“A mother’s diet that causes her to be overweight will be transmitted to the infant in several ways. Knowing what those microbes are and figuring out how they disrupt the child’s immune system is the focus of this study,” said Jed Friedman, Ph.D., director of Harold Hamm Diabetes Center and a principal investigator on the grant. Friedman’s past research in this area helped him attract the new federal grant. In his previous study, he took stool samples from 2-week-old infants who were born to obese mothers. Those samples, which contain the microbiome, were placed into mice that had no microbes of their own. The mice became obese and experienced a change in their immune systems.

“That prompted us to start thinking about what these microbes are and what they’re doing,” Friedman said. “They’re coming from the mother in some way, but they’re leaking out of the infants’ microbiomes and changing their immune systems and making them gain weight. There’s a super-highway from the gut to your liver. So anything that leaks out of the gut travels straight to the liver. Your liver is a prime target for these microbes.” Friedman’s current study will go a step further to determine how much of an infant’s microbiome disruption can be attributed to a mother’s diet during pregnancy vs. what the baby takes in during breastfeeding. Mice born to an obese mother will be placed with healthy-weight mice to breastfeed, and their immune system development will be monitored, he said.

The human microbiome is sometimes called the “undiscovered community within,” Friedman said, because it is 10 times the size of the human genome and extremely complicated because of how microbes act and communicate with each other. But for all its complexities, researchers have discovered ways to create a healthier microbiome, such as using probiotics in children who have immune conditions like allergies, he said. Part of this study will test the nutritional compound pyrroloquinoline quinone, or PQQ, for its ability to improve the microbiome. PQQ is an antioxidant found in green, leafy vegetables and, among other things, human breast milk, Friedman said. In the study, his team will investigate whether PQQ can counteract the microbial factors that lead to NAFLD.